PCS-2023 > 3 > 3E > 3E0 > 3E0D |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0D | Introduction, Mouth and Pharynx | |
3E0D3 | Percutaneous | |
3E0D30 | Antineoplastic | |
3E0D304 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach | |
3E0D305 | Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach | |
3E0D30M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach | |
3E0D32 | Anti-infective | |
3E0D328 | Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach | |
3E0D329 | Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach | |
3E0D33 | Anti-inflammatory | |
3E0D33Z | Introduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach | |
3E0D34 | Serum, Toxoid and Vaccine | |
3E0D34Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach | |
3E0D36 | Nutritional Substance | |
3E0D36Z | Introduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach | |
3E0D37 | Electrolytic and Water Balance Substance | |
3E0D37Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach | |
3E0D3B | Anesthetic Agent | |
3E0D3BZ | Introduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach | |
3E0D3H | Radioactive Substance | |
3E0D3HZ | Introduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach | |
3E0D3K | Other Diagnostic Substance | |
3E0D3KZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach | |
3E0D3N | Analgesics, Hypnotics, Sedatives | |
3E0D3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach | |
3E0D3R | Antiarrhythmic | |
3E0D3RZ | Introduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach | |
3E0D3T | Destructive Agent | |
3E0D3TZ | Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach | |
3E0D3G | Other Therapeutic Substance | |
3E0D3GC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach | |
3E0D7 | Via Natural or Artificial Opening | |
3E0D70 | Antineoplastic | |
3E0D704 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D705 | Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D70M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D72 | Anti-infective | |
3E0D728 | Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D729 | Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D73 | Anti-inflammatory | |
3E0D73Z | Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D74 | Serum, Toxoid and Vaccine | |
3E0D74Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D76 | Nutritional Substance | |
3E0D76Z | Introduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D77 | Electrolytic and Water Balance Substance | |
3E0D77Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7B | Anesthetic Agent | |
3E0D7BZ | Introduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7H | Radioactive Substance | |
3E0D7HZ | Introduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7K | Other Diagnostic Substance | |
3E0D7KZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7N | Analgesics, Hypnotics, Sedatives | |
3E0D7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7R | Antiarrhythmic | |
3E0D7RZ | Introduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7T | Destructive Agent | |
3E0D7TZ | Introduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0D7G | Other Therapeutic Substance | |
3E0D7GC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening | |
3E0DX | External | |
3E0DX0 | Antineoplastic | |
3E0DX04 | Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach | |
3E0DX05 | Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach | |
3E0DX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach | |
3E0DX2 | Anti-infective | |
3E0DX28 | Introduction of Oxazolidinones into Mouth and Pharynx, External Approach | |
3E0DX29 | Introduction of Other Anti-infective into Mouth and Pharynx, External Approach | |
3E0DX3 | Anti-inflammatory | |
3E0DX3Z | Introduction of Anti-inflammatory into Mouth and Pharynx, External Approach | |
3E0DX4 | Serum, Toxoid and Vaccine | |
3E0DX4Z | Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach | |
3E0DX6 | Nutritional Substance | |
3E0DX6Z | Introduction of Nutritional Substance into Mouth and Pharynx, External Approach | |
3E0DX7 | Electrolytic and Water Balance Substance | |
3E0DX7Z | Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach | |
3E0DXB | Anesthetic Agent | |
3E0DXBZ | Introduction of Anesthetic Agent into Mouth and Pharynx, External Approach | |
3E0DXH | Radioactive Substance | |
3E0DXHZ | Introduction of Radioactive Substance into Mouth and Pharynx, External Approach | |
3E0DXK | Other Diagnostic Substance | |
3E0DXKZ | Introduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach | |
3E0DXN | Analgesics, Hypnotics, Sedatives | |
3E0DXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach | |
3E0DXR | Antiarrhythmic | |
3E0DXRZ | Introduction of Antiarrhythmic into Mouth and Pharynx, External Approach | |
3E0DXT | Destructive Agent | |
3E0DXTZ | Introduction of Destructive Agent into Mouth and Pharynx, External Approach | |
3E0DXG | Other Therapeutic Substance | |
3E0DXGC | Introduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |